Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment - A review

Bayen, 2013, Occurrence and distribution of pharmaceutically active and endocrine disrupting compounds in Singapore’s marine environment: Influence of hydrodynamics and physical–chemical properties, Environ. Pollut., 182, 1, 10.1016/j.envpol.2013.06.028 Bayer, 2014, Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment, Environ. Sci. Pollut. Res., 21, 10830, 10.1007/s11356-014-3060-z Bendz, 2005, Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden, J. Hazard. Mater., 122, 195, 10.1016/j.jhazmat.2005.03.012 Berkner, 2014, Biodegradability and transformation of human pharmaceutical active ingredients in environmentally relevant test systems, Environ. Sci. Pollut. Res., 21, 9461, 10.1007/s11356-013-1868-6 Bouissou-Schurtz, 2014, Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey, Regul. Toxicol. Pharm., 69, 296, 10.1016/j.yrtph.2014.04.006 Boxall, 2014, Exploiting monitoring data in environmental exposure modeling and risk assessment of pharmaceuticals, Environ. Int., 73, 176, 10.1016/j.envint.2014.07.018 Brunton, L.L., Chabner, B.A., Knollmann, B.C., 2012. As Bases Farmacológicas da Terapêutica de Goodman e Gilman. 12. ed. AMGH, Porto Alegre. 2112 p. ISBN: 9788580551167. Carlsson, 2006, Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients, Sci. Total Environ., 364, 67, 10.1016/j.scitotenv.2005.06.035 Celiz, 2009, Pharmaceutical metabolites in the environment: analytical challenges and ecological risks, Environ. Toxicol. Chem., 28, 2473, 10.1897/09-173.1 Claessens, 2013, Emerging contaminants in Belgian marine waters: Single toxicant and mixture risks of pharmaceuticals, Mar. Pollut. Bull., 71, 41, 10.1016/j.marpolbul.2013.03.039 Cleuvers, 2003, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol. Lett., 142, 185, 10.1016/S0378-4274(03)00068-7 Cleuvers, 2005, Initial risk assessment for three β-blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090 Czech, 2014, Ecotoxicological evaluation of selected pharmaceuticals to Vibrio fischeri and Daphnia magna before and after photooxidation process, Ecotox. Environ. Safe., 104, 247, 10.1016/j.ecoenv.2014.03.024 Dietrich, 2010, Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna – a multigenerational study, Chemosphere, 79, 60, 10.1016/j.chemosphere.2009.12.069 Escher, 2006, Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach, Environ. Sci. Technol., 40, 7402, 10.1021/es052572v European Commission, 2003. Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment For New Notified Substances, Commission Regulation (EC) No 1488/94 on Risk Assessment For Existing Substances, Directive 98/8/EC of the European Parliament And Of The Council Concerning The Placing Of Biocidal Products On The Market-Part II, 328 pp. European Communities, 1967. Council Directive On The Approximation Of Laws, Regulations And Administrative Provisions Relating To The Classification, Packing and Labeling Of Dangerous Substances (67/548/EEC). Annex VI: General Classification And Labeling Requirements For Dangerous Substances And Preparations. Fatta-Kassinos, 2011, Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes – degradation, elucidation of byproducts and assessment of their biological potency, Chemosphere, 85, 693, 10.1016/j.chemosphere.2011.06.082 Feiner, 2014, Sublethal effects of the beta-blocker sotalol at environmentally relevant concentrations on the New Zealand mudsnail Potamopyrgus antipodarum, Environ. Toxicol. Chem., 33, 2510, 10.1002/etc.2699 Ferrari, 2004, Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environ. Toxicol. Chem., 23, 1344, 10.1897/03-246 Fick, J., Lindberg, R.H., Kaj, L., Brorström-Lundén, E., 2011. Results From The Swedish National Screening Programme 2010-Subreport 3. Pharmaceuticals. Swedish Environmental Research Institute. Franzellitti, 2011, The β-blocker propranolol affects cAMP dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis, Aquat. Toxicol., 101, 299, 10.1016/j.aquatox.2010.11.001 Franzellitti, 2013, The mode of action (MoA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis, Aquat. Toxicol., 140–141, 249, 10.1016/j.aquatox.2013.06.005 Fraysse, 2005, Prediction and experimental validation of acute toxicity of β-blockers in Ceriodaphnia dubia, Environ. Toxicol. Chem., 24, 2470, 10.1897/04-541R.1 Frias, M.C. 2013. Uso De Genéricos Contra Hipertensão Cresce 190%. <http://www1.folha.uol.com.br/colunas/mercadoaberto/2013/08/1323813-uso-de-genericos-contra-hipertensao-cresce-190.shtml> (accessed 02.02.15). Godoy, 2015, Ecotoxicological evaluation of propranolol hydrochloride and losartan potassium to Lemna minor L. (1753) individually and in binary mixtures, Ecotoxicology, 10.1007/s10646-015-1455-3 Grung, 2008, Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline, Ecotox. Environ. Safe., 71, 328, 10.1016/j.ecoenv.2007.10.015 Gu, 2012, Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: The National Health And Nutrition Examination Survey, 2001 to 2010, Circulation, 126, 2105, 10.1161/CIRCULATIONAHA.112.096156 Gust, 2013, Effects of short-term exposure to environmentally relevant concentrations of different pharmaceutical mixtures on the immune response of the pond snail Lymnaea stagnalis, Sci. Total Environ., 445–446, 210, 10.1016/j.scitotenv.2012.12.057 Hernando, 2004, Analysis by liquid chromatography-electrospray ionization tandem mass spectrometry and acute toxicity evaluation for β-blockers and lipid-regulating agents in wastewater samples, J. Chromatogr. A, 1046, 133 Huggett, 2002, Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-Blockers) on aquatic organisms, Arch. Environ. Contam. Toxicol., 43, 229, 10.1007/s00244-002-1182-7 Isidori, 2005, Toxic and genotoxic evaluation of six antibiotics on non-target organisms, Sci. Total Environ., 346, 87, 10.1016/j.scitotenv.2004.11.017 Kasprzyk-Hordern, 2009, The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters, Wat. Res., 43, 363, 10.1016/j.watres.2008.10.047 Kim, 2007, Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea, Environ. Int., 33, 370, 10.1016/j.envint.2006.11.017 Kim, 2009, Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes), J. Toxicol. Sci., 34, 227, 10.2131/jts.34.227 Klosterhaus, 2013, Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary, Environ. Int., 54, 92, 10.1016/j.envint.2013.01.009 Kostich, 2014, Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation, Environ. Pollut., 184, 354, 10.1016/j.envpol.2013.09.013 Küster, 2010, Environmental risk assessment of human pharmaceuticals in the European Union: a case study with the β-Blocker atenolol, Integr. Environ. Assess. Manag., 6, 514 Larsson, 2007, Effluent from drug manufactures contains extremely high levels of pharmaceuticals, J. Hazard. Mater., 148, 751, 10.1016/j.jhazmat.2007.07.008 Le, 2011, Toxicity evaluation of verapamil and tramadol based on toxicity assay and expression patterns of Dhb, Vtg, Arnt, CYP4 and CYP314 in Daphnia magna, Environ. Toxicol., 26, 515, 10.1002/tox.20665 Li, 2010, Ecotoxicological effects of short-term exposure to a human pharmaceutical verapamil in juvenile rainbow trout (Oncorhynchus mykiss), Comp. Biochem. Phys. C, 152, 385 López-Roldán, 2010, Advanced monitoring of pharmaceuticals and estrogens in the Llobregat River basin (Spain) by liquid chromatography–triple quadrupole-tandem mass spectrometry in combination with ultra-performance liquid chromatography–time of flight-mass spectrometry, Chemosphere, 80, 1337, 10.1016/j.chemosphere.2010.06.042 López-Serna, 2010, Fully automated determination of 74 pharmaceuticals in environmental and waste waters by online solid phase extraction–liquid chromatography-electrospray–tandem mass spectrometry, Talanta, 83, 410, 10.1016/j.talanta.2010.09.046 López-Serna, 2011, Development of a fast instrumental method for the analysis of pharmaceuticals in environmental and wastewaters based on ultra-high performance liquid chromatography (UHPLC)–tandem mass spectrometry (MS/MS), Chemosphere, 85, 1390, 10.1016/j.chemosphere.2011.07.071 López-Serna, 2013, Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain, Environ. Pollut., 174, 305, 10.1016/j.envpol.2012.11.022 Madureira, 2012, The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): evaluation of impacts on fish liver, by histopathology, stereology, vitellogenin and CYP1A immunohistochemistry, after sub-acute exposures of the zebrafish model, Environ. Toxicol. Phar., 34, 34, 10.1016/j.etap.2012.02.007 Margot, 2013, Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon?, Sci. Total Environ., 461–462, 480, 10.1016/j.scitotenv.2013.05.034 Maszkowska, 2014, Beta-blockers in the environment: Part I. Mobility and hydrolysis study, Sci. Total Environ., 493, 1112, 10.1016/j.scitotenv.2014.06.023 Maszkowska, 2014, Beta-blockers in the environment: Part II. Ecotoxicity study, Sci. Total. Environ., 493, 1122, 10.1016/j.scitotenv.2014.06.039 Maurer, 2007, Elimination of β-blockers in sewage treatment plants, Wat. Res., 41, 1614, 10.1016/j.watres.2007.01.004 Minguez, 2014, Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France, Environ. Sci. Pollut. Res. Int. Nalecz-Jawecki, 2006, Toxicity of selected pharmaceuticals to the anostracan crustacean Thamnocephalus platyurus – comparison of sublethal and lethal effect levels with the 1h Rapidtoxkit and the 24h Thamnotoxkit microbiotests, Environ. Sci. Pollut. R., 13, 22, 10.1065/espr2006.01.005 Nalecz-Jawecki, 2005, Influence of water hardness on the toxicity of selected pharmaceuticals and metals to the protozoa Spirostomum ambiguum and Tetrahymena termophila, Fresen. Environ. Bull., 14, 873 Nödler, 2013, Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle – a comparative study with selected b-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame, Wat. Res., 47, 6650, 10.1016/j.watres.2013.08.034 Nödler, 2014, Polar organic micropollutants in the coastal environment of different marine systems, Mar. Pollut. Bull., 85, 50, 10.1016/j.marpolbul.2014.06.024 Petersen, 2014, Combined effects of pharmaceuticals, personal care products, biocides and organic contaminants on the growth of Skeletonema pseudocostatum, Aquat. Toxicol., 150, 45, 10.1016/j.aquatox.2014.02.013 Piram, 2008, Photolysis of β-blockers in environmental waters, Chemosphere, 73, 1265, 10.1016/j.chemosphere.2008.07.018 Pomati, 2007, Gene expression profiles in zebrafish (Danio rerio) liver cells exposed to a mixture of pharmaceuticals at environmentally relevant concentrations, Chemosphere, 70, 65, 10.1016/j.chemosphere.2007.07.048 PróGenéricos – Associação Brasileira Das Indústrias De Medicamentos Genéricos, 2013. Saiba Quais São Os Genéricos Mais Vendidos No País. <http://www.progenericos.org.br/index.php/noticias/325-saiba-quais-sao-os-genericos-mais-vendidos-no-pais> (accessed 02.02.15). Radjenovic, 2007, Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor, Anal. Bioanal. Chem., 387, 1365, 10.1007/s00216-006-0883-6 Rhee, 2012, P-glycoprotein (P-gp) in the monogonont rotifer, Brachionus koreanus: molecular characterization and expression in response to pharmaceuticals, Aquat. Toxicol., 114–115, 104, 10.1016/j.aquatox.2012.02.009 Roberts, 2006, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Sci. Total Environ., 356, 143, 10.1016/j.scitotenv.2005.04.031 Romero, 2011, Photocatalytic treatment of metoprolol and propranolol, Catal. Today, 161, 115, 10.1016/j.cattod.2010.09.026 Santiago-Morales, 2013, Transformation products and reaction kinectics in simulated solar light photocatalytic degradation of propranolol using Ce-doped TiO2, Appl. Catal. B-Environ., 129, 13, 10.1016/j.apcatb.2012.09.023 Santos, 2010, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175, 45, 10.1016/j.jhazmat.2009.10.100 Santos, 2013, Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals, Sci. Total Environ., 461–462, 302, 10.1016/j.scitotenv.2013.04.077 Sauvé, 2014, A review of what is an emerging contaminant, Chem. Cent. J., 8, 15, 10.1186/1752-153X-8-15 Steibach, 2014, The sub-lethal effects and tissue concentration of the human pharmaceutical atenolol in rainbow trout (Oncorhynchus mykiss), Sci. Total Environ., 497–498, 209, 10.1016/j.scitotenv.2014.07.111 Steinbach, 2013, Toxic effects, bioconcentration and depuration of verapamil in the early life stages of common carp (Cyprinus carpio L.), Sci. Total Environ., 461–462, 198, 10.1016/j.scitotenv.2013.05.002 Sun, 2014, Toxicity and enantiospecific differences of two β-blockers, propranolol and metoprolol, in the embryos and larvae of zebrafish (Danio rerio), Environ. Toxicol., 29, 1367, 10.1002/tox.21867 Taylor, 2014, Human pharmaceutical products in the environment-the “problem” in perspective, Chemosphere, 115, 95, 10.1016/j.chemosphere.2014.01.011 Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Wat. Res., 32, 3245, 10.1016/S0043-1354(98)00099-2 van den Brandhof, 2010, Fish embryo toxicity of carbamazepine, diclofenac and metoprolol, Ecotox. Environ. Safe., 73, 1862, 10.1016/j.ecoenv.2010.08.031 Vannini, 2011, Effects of a complex mixture of therapeutic drugs on unicellular algae Pseudokirchneriella subcapitata, Aquat. Toxicol., 101, 459, 10.1016/j.aquatox.2010.10.011 Vasquez, 2014, Environmental side effects of pharmaceutical cocktails: what we know and what we should know, J. Hazard. Mater., 279, 169, 10.1016/j.jhazmat.2014.06.069 Verlicchi, 2012, Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Sci. Total Environ., 430, 109, 10.1016/j.scitotenv.2012.04.055 Walker, 2013, Molecular docking: a potential tool to aid ecotoxicity testing in environmental risk assessment of pharmaceuticals, Chemosphere, 93, 2568, 10.1016/j.chemosphere.2013.09.074 Wilde, 2012, Multivariate optimization of analytical methodology and a first attempt to an environmental risk assessment of β-blockers in hospital wastewater, J. Braz. Chem. Soc., 23, 1732, 10.1590/S0103-50532012005000035 Wille, 2010, Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater, Anal. Bioanal. Chem., 397, 1797, 10.1007/s00216-010-3702-z Xiao, 2015, Organic pollutants removal in wastewater by heterogeneous photocatalytic ozonation, Chemosphere, 121, 1, 10.1016/j.chemosphere.2014.10.072 Yamamoto, 2014, Avaliação dos efeitos biológicos adversos dos fármacos anti-hipertensivos Losartan e Valsartan em ouriço-do-mar Lytechinus variegatus (ECHINODERMATA, ECHINOIDEA), UNISANTA BioScience, 3, 27